Arteris: Bayview Legacy sells 95,099-share tranche
Both sale tranches were made under a Rule 10b5-1 plan adopted on December 12, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bayview Legacy, LLC sold 95,099 shares of Arteris, Inc. common stock at a weighted average price of $18.1856 per share and 4,901 shares at $18.8147 per share on November 2, 2026. The sales were made under a Rule 10b5-1 trading plan adopted by K. Charles Janac, Arteris’s President and CEO and Bayview Legacy’s manager, on December 12, 2025. After the transactions, Janac reported 154,337 directly held shares; the Charles and Lydia Janac Trust, for which he serves as trustee, held 56,252 shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 95,099 | $18.1856 | $1.73M |
| Sale | Common Stock F1, F4 | 4,901 | $18.8147 | $92K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F5 | -- | -- | -- |
Footnotes (5)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.72 to $18.71 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.
- F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.72 to $19.05 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sale price financial
dispositive power technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What price ranges did Bayview Legacy receive in its AIP sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.